Skip to main content
Clinical Trials/NL-OMON27989
NL-OMON27989
Recruiting
Not Applicable

A multicentre, randomized controlled trial of neurolysis for mild ulnar neuropathy at the elbow

dr. L.H. VisserSt Elisabeth Hospitalhilvarenbeekseweg 605022 GC Tilburgthe Netherlands013-5392552Fax 013-5422538E-mail l.visser@elisabeth.nldr. R. BeekmanAtrium Medical CentrePo Box 4446 6401 CX Heerlen the Netherlandsr.beekman@atriummc.nl045-5766700drs. A.H.C.M.L. SchreuderAtrium Medical CentrePo Box 4446 6401 CX Heerlen the NetherlandsTSR01@atriummc.nl045-57667000 sites120 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ulnar neuropathy, neurolysis, conservative treatmentulnaropathie, neurolyse, conservatief beleid
Sponsor
dr. L.H. VisserSt Elisabeth Hospitalhilvarenbeekseweg 605022 GC Tilburgthe Netherlands013-5392552Fax 013-5422538E-mail l.visser@elisabeth.nldr. R. BeekmanAtrium Medical CentrePo Box 4446 6401 CX Heerlen the Netherlandsr.beekman@atriummc.nl045-5766700drs. A.H.C.M.L. SchreuderAtrium Medical CentrePo Box 4446 6401 CX Heerlen the NetherlandsTSR01@atriummc.nl045-5766700
Enrollment
120
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
dr. L.H. VisserSt Elisabeth Hospitalhilvarenbeekseweg 605022 GC Tilburgthe Netherlands013-5392552Fax 013-5422538E-mail l.visser@elisabeth.nldr. R. BeekmanAtrium Medical CentrePo Box 4446 6401 CX Heerlen the Netherlandsr.beekman@atriummc.nl045-5766700drs. A.H.C.M.L. SchreuderAtrium Medical CentrePo Box 4446 6401 CX Heerlen the NetherlandsTSR01@atriummc.nl045-5766700

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18 years or more;
  • 2\. Clinical signs of an ulnar neuropathy (i.e., pain, numbness or paraesthesias in the area of the ulnar nerve, weakness or clumsiness of ulnar muscles);

Exclusion Criteria

  • 1\. Evidence of a coexistent polyneuropathy;
  • 2\. History of hereditary neuropathy with liability to pressure palsies;

Outcomes

Primary Outcomes

Not specified

Similar Trials